Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.
Duluc C, Moatassim-Billah S, Chalabi-Dchar M, Perraud A, Samain R, Breibach F, Gayral M, Cordelier P, Delisle MB, Bousquet-Dubouch MP, Tomasini R, Schmid H, Mathonnet M, Pyronnet S, Martineau Y, Bousquet C.
Duluc C, et al. Among authors: bousquet dubouch mp, bousquet c.
EMBO Mol Med. 2015 Jun;7(6):735-53. doi: 10.15252/emmm.201404346.
EMBO Mol Med. 2015.
PMID: 25834145
Free PMC article.